Literature DB >> 6277956

Intra- and intermolecular strand transfer by HeLa DNA topoisomerase I.

B D Halligan, J L Davis, K A Edwards, L F Liu.   

Abstract

The major type I DNA topoisomerase (topo I) has been purified from HeLa cell nuclei to a homogeneous, monomeric protein (Mr = 100,000). Similar to the nicking-closing enzyme (Mr = 67,000) from rat liver (Been, M. D., and Champoux, J. J. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 2883-2887), HeLa topo I has the following properties: (a) HeLa topo I breaks down single-stranded DNA to smaller fragments, each with an enzyme-linked 3'-phosphoryl end and a free 5'-OH end. This cleavage is not dependent upon protein denaturant or protease treatment. (b) HeLa topo I produces single-stranded DNA circles from linear single-stranded DNA. Such DNA circles are believed to be produced by the intramolecular cyclization of topo I-linked, single-stranded DNA fragments. (c) HeLa topo I-linked, single-stranded fragments (donors) can join covalently to double-stranded DNA possessing a 5'-OH group (acceptors). The donor is transferred to the 5'-OH end of the acceptor, independent of the position of the end (internal nick or end of linear DNA) or the configuration of the end (flush, 5'-protruding, or 5'-recessed end) of the acceptor. (d) HeLa topo I cleavage of single-stranded DNA is site-specific, but no special sequence at the ends of the acceptor molecule is apparently required for a successful heterologous strand transfer. These results suggest that HeLa topo I may be involved in DNA sequence rearrangements in addition to its possible role as a swivelase for transcription and replication.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277956

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Recombinogenic flap ligation pathway for intrinsic repair of topoisomerase IB-induced double-strand breaks.

Authors:  C Cheng; S Shuman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

3.  Topoisomerase I-mediated integration of hepadnavirus DNA in vitro.

Authors:  H P Wang; C E Rogler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Multigene family of ribosomal DNA in Drosophila melanogaster reveals contrasting patterns of homogenization for IGS and ITS spacer regions. A possible mechanism to resolve this paradox.

Authors:  C Polanco; A I González; G A Dover
Journal:  Genetics       Date:  1998-05       Impact factor: 4.562

5.  Enzymes used in molecular biology: a useful guide.

Authors:  Laure Rittié; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-03       Impact factor: 5.782

Review 6.  In vitro assays used to measure the activity of topoisomerases.

Authors:  J F Barrett; J A Sutcliffe; T D Gootz
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

7.  Mapping in vivo topoisomerase I sites on simian virus 40 DNA: asymmetric distribution of sites on replicating molecules.

Authors:  S E Porter; J J Champoux
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

8.  Topoisomerase I sites cluster asymmetrically at the ends of the simian virus 40 core origin of replication.

Authors:  S Tsui; M E Anderson; P Tegtmeyer
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Enrichment and depletion of Hela topoisomerase I recognition sites among specific types of DNA elements.

Authors:  C Perez-Stable; C C Shen; C K Shen
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

10.  Mechanistic study of E. coli DNA topoisomerase I: cleavage of oligonucleotides.

Authors:  Y C Tse-Dinh; B G McCarron; R Arentzen; V Chowdhry
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.